Report Categories
View AllRecent Articles
View All
Core Laboratories HAL Q1 2026 Earnings Geopolitical Headwinds Weigh on NearTerm Results LongTerm Growth Trajectory Remains Intact
How Actuate ACTU maintains its competitive edge Actuate posts 28 EPS upside on narrower Q4 loss
MYGN Myriad Genetics Q1 earnings miss by 289 percent as EPS decline overshadows flat revenue performance
Is NICE Ltd NICE stock losing upward strength Nudges Up 20260427